Objective: Studies of the association between transportation barriers and HIV-related health outcomes have shown both positive and negative effects, possibly because a reliable, validated measure of transportation barriers has not been identified.
Design: Prospective cohort study of HIV-infected patients in rural Uganda.
Methods: Participants were enrolled from the HIV clinic at the regional referral hospital in Mbarara, Uganda as part of the Uganda AIDS Rural Treatment Outcomes (UARTO) Study. We collected the following measures of transportation barriers to HIV clinic: global positioning systems (GPS)-tracked distance measured by driving participants to their homes along their typical route; straight-line GPS distance from clinic to home, calculated with the Great Circle Formula; self-reported travel time; and self-reported travel cost. We assessed inter-measure agreement using linear regression, correlation coefficients and κ statistics (by measure quartile) and validated measures by fitting linear regression models to estimate associations with days late for clinic visits.
Results: One hundred and eighty-eight participants were tracked with GPS. Seventy-six percent were women, with a median age of 40 years and median CD4 cell count of 193 cells/μl. We found a high correlation between GPS-based distance measures (β = 0.74, P < 0.001, R2 = 0.92, κ = 0.73), but little correlation between GPS-based and self-reported measures (all R2 ≤ 0.4). GPS-based measures were associated with days late to clinic (P < 0.001); but neither self-reported measure was associated (P > 0.85).
Conclusion: GPS-measured distance to clinic is associated with HIV clinic absenteeism and should be prioritized over self-reported measures to optimally risk-stratify patients accessing care in rural, resource-limited settings.
aMassachusetts General Hospital Center for Global Health, Boston
bDepartment of Psychiatry, Chester M. Pierce MD Division of Global Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA
cMbarara University of Science and Technology, Mbarara, Uganda
dUniversitiy of California, San Francisco, USA
eMassachusetts General Hospital Center for Global Health, Ragon Institute of Massachusetts General Hospital MIT and Harvard, and Harvard Medical School, Boston, Massachusetts, USA.
Correspondence to Mark Siedner, Massachusetts General Hospital, Division of Infectious Diseases, 55 Fruit St., GRJ-5, Boston, MA 02114, USA. Tel: +1 617 732 6829; e-mail: email@example.com
Received 27 November, 2012
Revised 29 December, 2012
Accepted 5 February, 2013